Back
Cullinan Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
CGEM
Cullinan Therapeutics, Inc.
Last Price:
$14.45
Seasonality Move:
-4.1%
7 Day Trial
ALL ACCESS PASS
$
7
Cullinan Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Cullinan Therapeutics, Inc. has on average historically risen by 4.2% based on the past 5 years of stock performance.
-
Cullinan Therapeutics, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Cullinan Therapeutics, Inc. Stock Undervalued?The current Cullinan Therapeutics, Inc. [CGEM] share price is $14.43. The Score for CGEM is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
CGEM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Cullinan Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Cullinan Therapeutics, Inc. has on average historically risen by 4.2% based on the past 5 years of stock performance.
Cullinan Therapeutics, Inc. Stock Rating
Sell
42
Cullinan Therapeutics, Inc. (CGEM)
is a Sell
Is Cullinan Therapeutics, Inc. overpriced?
-
Cullinan Therapeutics, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Cullinan Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cullinantherapeutics.com
52-Week Data
52-Week High:
16.74
52-Week Low:
5.68
Prediction Charts
Market Cap:
905M
Price in USD:
14.43
Volume:
1.1M
Beta:
-0.10
Technical Analysis
SMA50:
13.46
SMA100:
11.88
SMA200:
9.64
52-Wk Change:
84.53%
Stock Predictions
-
Is Cullinan Therapeutics, Inc. stock public?Yes, Cullinan Therapeutics, Inc. is a publicly traded company.
-
What is the Cullinan Therapeutics, Inc. stock quote today?The Cullinan Therapeutics, Inc. stock price is 14.43 USD today.
-
How to buy Cullinan Therapeutics, Inc. stock online?You can buy Cullinan Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 14.03 | 14.03 | 14.50 | 13.76 |
| Mar-17 | 13.91 | 13.44 | 14.08 | 13.41 |
| Mar-18 | 13.42 | 13.13 | 13.48 | 13.05 |
| Mar-19 | 12.95 | 13.08 | 13.32 | 12.66 |
| Mar-20 | 13.03 | 12.74 | 13.22 | 12.65 |
| Mar-23 | 13.07 | 12.84 | 13.80 | 12.51 |
| Mar-24 | 12.70 | 13.64 | 13.75 | 12.40 |
| Mar-25 | 13.87 | 14.06 | 14.74 | 13.79 |
| Mar-26 | 13.88 | 13.67 | 14.29 | 13.62 |
| Mar-27 | 13.57 | 12.85 | 13.78 | 12.79 |
| Mar-30 | 12.82 | 13.42 | 13.51 | 12.63 |
| Mar-31 | 13.66 | 14.21 | 14.52 | 13.52 |
| Apr-1 | 14.30 | 13.94 | 14.81 | 13.92 |
| Apr-2 | 13.51 | 14.43 | 14.62 | 13.51 |
Cullinan Therapeutics, Inc. Earnings
Cullinan Therapeutics, Inc. Earnings Report: Per Share Cullinan Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cullinan Therapeutics, Inc. Forecast Revenue Growth
Cullinan Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Cullinan Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and an increase next year of $0.18 per share.
* Cullinan Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.